210 related articles for article (PubMed ID: 8201324)
1. Motor response to apomorphine and levodopa in asymmetric Parkinson's disease.
Rodriguez M; Lera G; Vaamonde J; Luquin MR; Obeso JA
J Neurol Neurosurg Psychiatry; 1994 May; 57(5):562-6. PubMed ID: 8201324
[TBL] [Abstract][Full Text] [Related]
2. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon.
Colosimo C; Merello M; Hughes AJ; Sieradzan K; Lees AJ
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):634-7. PubMed ID: 8648329
[TBL] [Abstract][Full Text] [Related]
3. Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.
Bravi D; Mouradian MM; Roberts JW; Davis TL; Sohn YH; Chase TN
Ann Neurol; 1994 Jul; 36(1):27-31. PubMed ID: 8024257
[TBL] [Abstract][Full Text] [Related]
4. Motor response to apomorphine and levodopa in asymmetric Parkinson's disease.
Kempster PA; Lees AJ
J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1444. PubMed ID: 7964840
[No Abstract] [Full Text] [Related]
5. [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease.
Kumar A; Mann S; Sossi V; Ruth TJ; Stoessl AJ; Schulzer M; Lee CS
Brain; 2003 Dec; 126(Pt 12):2648-55. PubMed ID: 12937076
[TBL] [Abstract][Full Text] [Related]
6. The motor response to repeated apomorphine administration in Parkinson's disease.
Hughes AJ; Bishop S; Stern GM; Lees AJ
Clin Neuropharmacol; 1991 Jun; 14(3):209-13. PubMed ID: 2070362
[TBL] [Abstract][Full Text] [Related]
7. Motor response to apomorphine in patients with Parkinson's disease with long-duration response to levodopa.
Bonuccelli U; Napolitano A; Del Dotto P; Quattrone A
Clin Neuropharmacol; 2002; 25(2):119-21. PubMed ID: 11981241
[TBL] [Abstract][Full Text] [Related]
8. Motor response to repeated dopaminergic stimulation in Parkinson's disease.
Obeso JA; Luquin MR; Grandas F; Vaamonde J; Laguna J; Martinez-Lage JM
Clin Neuropharmacol; 1992 Feb; 15(1):75-9. PubMed ID: 1349508
[TBL] [Abstract][Full Text] [Related]
9. Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease.
Merello M; Lees AJ
J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1024-6. PubMed ID: 1469397
[TBL] [Abstract][Full Text] [Related]
10. Apomorphine infusion and the long-duration response to levodopa in advanced Parkinson's disease.
Stocchi F; Berardelli A; Vacca L; Barbato L; Monge A; Nordera G; Ruggieri S
Clin Neuropharmacol; 2003; 26(3):151-5. PubMed ID: 12782918
[TBL] [Abstract][Full Text] [Related]
11. Motor response following repeated apomorphine administration is reduced in Parkinson's disease.
Grandas F; Obeso JA
Clin Neuropharmacol; 1989 Feb; 12(1):14-22. PubMed ID: 2713864
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.
Deleu D; Hanssens Y; Northway MG
Drugs Aging; 2004; 21(11):687-709. PubMed ID: 15323576
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the clinical pharmacology of (-)NPA and levodopa in Parkinson's disease.
Mouradian MM; Heuser IJ; Baronti F; Giuffra M; Conant K; Davis TL; Chase TN
J Neurol Neurosurg Psychiatry; 1991 May; 54(5):401-5. PubMed ID: 1865201
[TBL] [Abstract][Full Text] [Related]
14. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
Chen JJ; Obering C
Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
[TBL] [Abstract][Full Text] [Related]
15. Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's disease.
Grandas F; Gancher ST; Rodriguez M; Lera G; Nutt JG; Obeso JA
Clin Neuropharmacol; 1992 Feb; 15(1):13-8. PubMed ID: 1576595
[TBL] [Abstract][Full Text] [Related]
16. Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations.
Nyholm D; Constantinescu R; Holmberg B; Dizdar N; Askmark H
Acta Neurol Scand; 2009 May; 119(5):345-8. PubMed ID: 18822087
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of levodopa coadministered with apomorphine in parkinsonian patients with end-of-dose motor fluctuations.
Baas H; Harder S; Bürklin F; Demisch L; Fischer PA
Clin Neuropharmacol; 1998; 21(2):86-92. PubMed ID: 9579293
[TBL] [Abstract][Full Text] [Related]
18. [Proposed alternative to standard apomorphine challenge test].
Martínez-Castrillo JC; Burguera JA
Rev Neurol; 2012; 55 Suppl 1():S11-3. PubMed ID: 23169227
[TBL] [Abstract][Full Text] [Related]
19. The duration of the motor response to apomorphine boluses is conditioned by the length of a prior infusion in Parkinson's disease.
Vaamonde J; Flores JM; Weisser R; Ibañez R; Obeso JA
Mov Disord; 2009 Apr; 24(5):762-5. PubMed ID: 19224589
[TBL] [Abstract][Full Text] [Related]
20. Apomorphine continuous stimulation in Parkinson's disease: receptor desensitization as a possible mechanism of reduced motor response.
Maggio R; Barbier P; Corsini GU
J Neural Transm Suppl; 1995; 45():133-6. PubMed ID: 8748618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
